Skip to content
Congress·In Committee·26 days ago

House Bill Would Create $400M Program to Provide Free PrEP to Uninsured, Rural Americans

Also known as: PrEP Assistance Program Act

Legislative Progress

Filed
Review
House
Senate
President

Impact Analysis

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Key Points

  • This bill would create a new grant program to help clinics and local governments provide PrEP, which is a medicine that helps prevent people from getting HIV. The program would focus on reaching people in rural areas, those without health insurance, and groups that are at a higher risk of getting the virus.
  • People who get help through these programs would not have to pay for the medicine, doctor visits, or lab tests. The plan also encourages using creative ways to reach people, such as mobile clinics, health vending machines, and 'pop-up' centers in the community.
  • A new 'PrEP Pass' would be created for people without health insurance. This card would allow them to get HIV prevention drugs and necessary blood or urine tests from participating doctors and pharmacies at no cost to the patient.
  • Congress would set aside $400 million every year from 2027 through 2031 to pay for these services. This money would also cover extra support like transportation to the doctor, mental health services, and training for healthcare workers to better serve their patients.
Healthcare

Milestones

2 milestones2 actions
Feb 4, 2026House

Referred to the House Committee on Energy and Commerce.

Feb 4, 2026

Introduced in House

Related News

1 article

Source Information

Document Type

Congressional Bill

Official Title

PrEP Assistance Program Act

Bill NumberHR 7385
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the House Committee on Energy and Commerce.

Sponsor

Cosponsors

(12)
D: 12

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.